Autor/in Eifrig, Barbara Externest, D 1 Ganser, A Kreuz, W 1 Lenk, H 1 Pabinger, I 1 Pollmann, H 1 Schramm, W 1 Schwarz, T F 1 Zavazava, N Zimmermann, R 1 alle zeigenListe einklappen
Efficacy, safety and tolerability of recombinant factor VIII (REFACTO) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria. Pollmann, H Externest, D Ganser, A Eifrig, Barbara Kreuz, W Lenk, H Pabinger, I 2007 - Forschungsinformationssystem des UKE
